Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study

Figure 5

Digestive symptoms under Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Digestive symptoms were assessed by use of EORTC QLQ-C30 [14] and displayed as difference (Δ before − after). Statistical significance () is highlighted (bold) and small (SCD) and modest (MCD) clinically relevant differences [15] are illustrated by dashed lines.

(a)

(b)

(c)

(d)